SMTL ID : 4k1l.1

4,4-Dioxo-5,6-dihydro-[1,4,3]oxathiazines, a novel class of 11 beta-HSD1 inhibitors for the treatment of diabetes

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.96 Å

Oligo State

homo-tetramer

Ligands

4 x SFF: (4aS,8aR)-N-cyclohexyl-4a,5,6,7,8,8a-hexahydro-4,1,2-benzoxathiazin-3-amine 1,1-dioxide(Non-covalent)

SFF.1: 15 residues within 4Å: Chain A: I.115, T.118, L.120, S.164, L.165, A.166, Y.171, V.174, Y.177, L.209, G.210, L.211, T.216, V.221 Ligands: NDP.2 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:I.115, A:L.120, A:Y.171, A:V.174, A:L.211, A:T.216, A:V.221 Hydrogen bonds: A:S.164, A:L.165, A:A.166, A:Y.177, A:Y.177 SFF.3: 14 residues within 4Å: Chain B: I.115, T.118, L.120, S.164, L.165, A.166, Y.171, Y.177, L.209, G.210, L.211, T.216, V.221 Ligands: NDP.4 11 PLIP interactions: 11 interactions with chain B Hydrophobic interactions: B:I.115, B:L.120, B:Y.171, B:L.211, B:T.216, B:V.221 Hydrogen bonds: B:S.164, B:L.165, B:A.166, B:Y.177 Water bridges: B:L.211 SFF.5: 15 residues within 4Å: Chain C: I.115, T.118, L.120, S.164, L.165, A.166, Y.171, V.174, Y.177, L.209, G.210, L.211, T.216, V.221 Ligands: NDP.6 12 PLIP interactions: 12 interactions with chain C Hydrophobic interactions: C:I.115, C:L.120, C:Y.171, C:V.174, C:L.211, C:T.216, C:V.221 Hydrogen bonds: C:S.164, C:L.165, C:A.166, C:Y.177 Water bridges: C:L.211 SFF.7: 13 residues within 4Å: Chain D: T.118, L.120, S.164, L.165, A.166, Y.171, Y.177, L.209, G.210, L.211, T.216, V.221 Ligands: NDP.8 12 PLIP interactions: 12 interactions with chain D Hydrophobic interactions: D:T.118, D:L.120, D:Y.171, D:Y.171, D:L.211, D:T.216, D:V.221 Hydrogen bonds: D:S.164, D:L.165, D:A.166, D:Y.177, D:Y.177

4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NDP.2: 30 residues within 4Å: Chain A: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, E.88, N.113, H.114, I.115, Y.141, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: SFF.1 26 PLIP interactions: 26 interactions with chain A Hydrophobic interactions: A:L.209, A:I.212 Hydrogen bonds: A:G.35, A:S.37, A:S.37, A:K.38, A:I.40, A:R.60, A:S.61, A:T.86, A:M.87, A:E.88, A:N.113, A:N.113, A:I.115, A:Y.141, A:K.181, A:I.212, A:T.214, A:T.214, A:T.216 Water bridges: A:K.38, A:K.38, A:G.41 Salt bridges: A:K.38, A:R.60 NDP.4: 28 residues within 4Å: Chain B: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, N.113, H.114, I.115, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: SFF.3 28 PLIP interactions: 28 interactions with chain B Hydrophobic interactions: B:L.209 Hydrogen bonds: B:S.37, B:S.37, B:K.38, B:K.38, B:I.40, B:R.60, B:S.61, B:T.86, B:T.86, B:M.87, B:N.113, B:N.113, B:I.115, B:Y.141, B:Y.177, B:K.181, B:I.212, B:I.212, B:T.214, B:T.214 Water bridges: B:G.41, B:T.116, B:T.116, B:T.216, B:T.216 Salt bridges: B:K.38, B:R.60 NDP.6: 29 residues within 4Å: Chain C: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, N.113, H.114, I.115, Y.141, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: SFF.5 32 PLIP interactions: 32 interactions with chain C Hydrophobic interactions: C:L.209 Hydrogen bonds: C:G.35, C:S.37, C:S.37, C:K.38, C:I.40, C:R.60, C:S.61, C:T.86, C:T.86, C:M.87, C:N.113, C:N.113, C:I.115, C:S.164, C:Y.177, C:K.181, C:I.212, C:T.214, C:T.214, C:T.214 Water bridges: C:S.37, C:K.38, C:G.41, C:R.60, C:E.88, C:T.116, C:T.116, C:N.117, C:T.216 Salt bridges: C:K.38, C:R.60 NDP.8: 29 residues within 4Å: Chain D: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, E.88, N.113, H.114, I.115, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: SFF.7 28 PLIP interactions: 28 interactions with chain D Hydrophobic interactions: D:L.209 Hydrogen bonds: D:G.35, D:S.37, D:S.37, D:K.38, D:I.40, D:R.60, D:S.61, D:T.86, D:M.87, D:E.88, D:N.113, D:N.113, D:I.115, D:S.164, D:K.181, D:I.212, D:I.212, D:T.214, D:T.216 Water bridges: D:S.37, D:K.38, D:K.38, D:G.41, D:S.61, D:T.214 Salt bridges: D:K.38, D:R.60

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bohme, T. et al., 1,1-Dioxo-5,6-dihydro-[4,1,2]oxathiazines, a novel class of 11-HSD1 inhibitors for the treatment of diabetes. Bioorg.Med.Chem.Lett. (2013)

Release Date

2014-04-09

Peptides

Corticosteroid 11-beta-dehydrogenase isozyme 1: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Corticosteroid 11-beta-dehydrogenase isozyme 1

Related Entries With Identical Sequence